POST Online Media Lite Edition


Opioid crisis: Insys Therapeutics executive sentenced to 3 years in prison for lying

Christian Fernsby |
An Insys Therapeutics executive will spend 33 months in prison and forfeit $3.6 million for his role in an illicit fentanyl spray prescription scheme, a federal judge ruled Monday after victims shared the harrowing details of how the opioid destroyed their lives.

Article continues below


Michael Gurry, convicted on a racketeering charge last year with four other Insys executives, ran the Insys Reimbursement Center which tricked insurers into paying for prescriptions of the fentanyl spray Subsys, allowed only to treat breakthrough cancer pain, for patients who didn’t need the powerful medicine, prosecutors say.

A prosecutor, who requested an 11-year sentence, appeared to question Gurry’s sincerity, briefly standing up and objecting to his statement.

Burroughs agreed to recommend Gurry serve his sentence at a Pensacola minimum security federal prison. She said she’d like to see Gurry have time to pay back his restitution, which was calculated separately from the $3.6 million forfeiture ordered by the court, and which was not determined Monday afternoon. A fine was not issued.

What to read next

AG Porrino files lawsuit alleging greed-driven scheme by Insys Therapeutics
Founder of Insys Therapeutics arrested and charged with racketeering
U.S. accusing Insys Therapeutics of promoting powerful opioid